Title of Collaborative Activity: |
U.S. FDA Medical Imaging Drugs Advisory Committee |
Description of Collaborative Activity: |
The Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in diagnostic and therapeutic procedures using radioactive pharmaceuticals and contrast media used in diagnostic radiology and makes appropriate recommendations to the Commissioner of Food and Drugs. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2015 |
NIH Participating Institutes/Centers/Office of the Director: |
CC |
HHS Agency Collaborators on this Activity: |
FDA |
